Shares of Moderna fell 3.25% to $150.03 at 11:10 EST on Tuesday, following yesterday’s downward trend. The Nasdaq Stock Market is jumping 0.74% to $12,532.50, following yesterday’s upward trend, This seems, so far, a somewhat positive trend exchanging session today.

Moderna’s last close was $155.07, 18.98% below its 52-week high of $178.50.

News about Moderna today

Take-two, occidental petroleum, Moderna: what to watch when the stock market opens today. According to today’s article on The Wall Street Journal, "-Shares of the vaccine maker Moderna were down 1% premarket. "

Moderna vaccine found safe, effective ahead of key FDA review. According to today’s article on Bloomberg Quint, "Once the U.S. grants authorization, advisers to the Centers for Disease Control and Prevention must meet, as they did last week on Pfizer’s vaccine, to give Moderna’s shot the green light and provide offer specific recommendations for use and monitoring. ", "The shot must be kept extremely cold and requires special freezers to transport, while Moderna’s can be kept in more traditional cold storage."

Moderna vaccine found safe, effective before key FDA review. According to today’s article on Bloomberg Quint, "In addition, there were two cases of serious facial swelling in vaccine recipients that Moderna determined were related to vaccination. ", "The shot must be kept extremely cold and requires special freezers to transport, while Moderna’s can be kept in more traditional cold storage."

Moderna shares up in premarket as FDA calls covid-19 vaccine 'highly effective'. According to today’s article on MarketWatch, "Shares of Moderna Inc. gained 1.5% in premarket trading on Tuesday after the Food and Drug Administration said the company’s COVID-19 vaccine candidate is “highly effective” at preventing infections with the coronavirus. "

Moderna’s Sales

Moderna’s sales growth is 1428.1% for the present quarter and 13065.3% for the next. The company’s growth estimates for the current quarter is a negative 48.6% and positive 565.7% for the next.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.

Moderna’s Stock Top and Bottom Yearly Value

Moderna’s stock is valued at $150.03 at 11:10 EST, way below its 52-week high of $178.50 and way above its 52-week low of $17.68.

Moderna’s Moving Average

Moderna’s value is way above its 50-day moving average of $106.15 and way higher than its 200-day moving average of $77.98.

Previous days news about Moderna

Moderna offers U.S. fail-safe on vaccines if Pfizer falls short. According to Bloomberg Quint on Thu Dec 10, "If the U.S. doesn’t lock in the full 400 million extra doses, it could free up capacity for Moderna to sell more supply to other countries, potentially at a higher price.", "If it reaches the higher end of that range, Moderna could meet most of the U.S. demand for a coronavirus vaccine, Morgan Stanley analyst Matthew Harrison said in a note to clients on Dec. 8."

Moderna says U.S. to buy 100 million additional vaccine doses. According to Bloomberg Quint on Fri Dec 11, "Moderna said Friday that the order, worth $1.65 billion, would be delivered during the second quarter of 2021. ", "As part of Operation Warp Speed, the U.S. initiative to rapidly develop and secure vaccines for Covid-19, the U.S. has the option to buy another 300 million doses from Moderna at a fixed price of $16.50 per shot, the company said. "

LEAVE A REPLY

Please enter your comment!
Please enter your name here